Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ipsita Volety

Showing results (1-10 of 12) with videos related to

Pageof 2
Sort By:
Pharmaceutics|October 23, 2021
Aptamers in Virology-A Consolidated Review of the Most Recent Advancements in Diagnosis and TherapyTejabhiram Yadavalli, Ipsita Volety, Deepak Shukla
Mbio|November 29, 2023
OPTN-TBK1 axis and a role for PLK1 in HSV-1 infectionIlina Bhattacharya, Ipsita Volety, Deepak Shukla
Journal of Visualized Experiments : Jove|October 4, 2021
Porcine Corneal Tissue Explant to Study the Efficacy of Herpes Simplex Virus-1 AntiviralsTejabhiram Yadavalli, Ipsita Volety, Deepak Shukla
Viruses|January 8, 2025
Heparanase 2 Modulation Inhibits HSV-2 Replication by Regulating Heparan SulfateJames Hopkins, Ipsita Volety, Farreh Qatanani, et al.
Antiviral Research|May 8, 2020
BX795 demonstrates potent antiviral benefits against herpes simplex Virus-1 infection of human cell linesAqsa Iqbal, Rahul Suryawanshi, Tejabhiram Yadavalli, et al.
Antiviral Research|March 26, 2022
Erratum to "BX795 demonstrates potent antiviral benefits against herpes simplex Virus-1 infection of human cell lines" [Antivir. Res. 80 (2020) 104814]Aqsa Iqbal, Rahul Suryawanshi, Tejabhiram Yadavalli, et al.
Frontiers in Cellular and Infection Microbiology|February 4, 2021
Herpes Simplex Virus Cell Entry Mechanisms: An UpdateKrishnaraju Madavaraju, Raghuram Koganti, Ipsita Volety, et al.
Investigative Ophthalmology & Visual Science|November 28, 2023
Unique Attributes of Guinea Pigs as New Models to Study Ocular Herpes Pathophysiology and RecurrenceTejabhiram Yadavalli, Chandrashekhar Patil, Pankaj Sharma, et al.
Antimicrobial Agents and Chemotherapy|July 1, 2020
<i>In Vitro</i> and <i>In Vivo</i> Activity, Tolerability, and Mechanism of Action of BX795 as an Antiviral against Herpes Simplex Virus 2 Genital InfectionJames Hopkins, Tejabhiram Yadavalli, Rahul Suryawanshi, et al.
Clinical and Translational Medicine|June 10, 2025
MLKL‒OPTN axis regulates herpesvirus-induced neurological sequelaeIlina Bhattacharya, Rashmi Kadam, Tejabhiram Yadavalli, et al.
Pageof 2

Showing results (1-10 of 12) with videos related to

Sort By:
Pageof 2
Pharmaceutics|October 23, 2021
Aptamers in Virology-A Consolidated Review of the Most Recent Advancements in Diagnosis and TherapyTejabhiram Yadavalli, Ipsita Volety, Deepak Shukla
Mbio|November 29, 2023
OPTN-TBK1 axis and a role for PLK1 in HSV-1 infectionIlina Bhattacharya, Ipsita Volety, Deepak Shukla
Journal of Visualized Experiments : Jove|October 4, 2021
Porcine Corneal Tissue Explant to Study the Efficacy of Herpes Simplex Virus-1 AntiviralsTejabhiram Yadavalli, Ipsita Volety, Deepak Shukla
Viruses|January 8, 2025
Heparanase 2 Modulation Inhibits HSV-2 Replication by Regulating Heparan SulfateJames Hopkins, Ipsita Volety, Farreh Qatanani, et al.
Antiviral Research|May 8, 2020
BX795 demonstrates potent antiviral benefits against herpes simplex Virus-1 infection of human cell linesAqsa Iqbal, Rahul Suryawanshi, Tejabhiram Yadavalli, et al.
Antiviral Research|March 26, 2022
Erratum to "BX795 demonstrates potent antiviral benefits against herpes simplex Virus-1 infection of human cell lines" [Antivir. Res. 80 (2020) 104814]Aqsa Iqbal, Rahul Suryawanshi, Tejabhiram Yadavalli, et al.
Frontiers in Cellular and Infection Microbiology|February 4, 2021
Herpes Simplex Virus Cell Entry Mechanisms: An UpdateKrishnaraju Madavaraju, Raghuram Koganti, Ipsita Volety, et al.
Investigative Ophthalmology & Visual Science|November 28, 2023
Unique Attributes of Guinea Pigs as New Models to Study Ocular Herpes Pathophysiology and RecurrenceTejabhiram Yadavalli, Chandrashekhar Patil, Pankaj Sharma, et al.
Antimicrobial Agents and Chemotherapy|July 1, 2020
<i>In Vitro</i> and <i>In Vivo</i> Activity, Tolerability, and Mechanism of Action of BX795 as an Antiviral against Herpes Simplex Virus 2 Genital InfectionJames Hopkins, Tejabhiram Yadavalli, Rahul Suryawanshi, et al.
Clinical and Translational Medicine|June 10, 2025
MLKL‒OPTN axis regulates herpesvirus-induced neurological sequelaeIlina Bhattacharya, Rashmi Kadam, Tejabhiram Yadavalli, et al.
Pageof 2